The use of TIMP2 × IGFBP7 biomarkers at admission could, therefore, be helpful in the trauma setting, where implementation of an AKI care bundle to prevent or interrupt the mitigation of kidney damage is possible. The gene discussed is IGFBP7; the disease is acute kidney injury.